TAK logo

TAK Total assets

annual total assets:

$95.22B-$4.60B(-4.61%)
March 1, 2025

Summary

  • As of today (May 29, 2025), TAK annual total assets is $95.22 billion, with the most recent change of -$4.60 billion (-4.61%) on March 1, 2025.
  • During the last 3 years, TAK annual total assets has fallen by -$12.75 billion (-11.81%).
  • TAK annual total assets is now -23.45% below its all-time high of $124.40 billion, reached on March 31, 2019.

Performance

TAK Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKbalance sheet metrics

quarterly total assets:

$95.22B-$978.70M(-1.02%)
March 1, 2025

Summary

  • As of today (May 29, 2025), TAK quarterly total assets is $95.22 billion, with the most recent change of -$978.70 million (-1.02%) on March 1, 2025.
  • Over the past year, TAK quarterly total assets has dropped by -$4.60 billion (-4.61%).
  • TAK quarterly total assets is now -24.18% below its all-time high of $125.59 billion, reached on June 30, 2019.

Performance

TAK quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTAKbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

TAK Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.6%-4.6%
3 y3 years-11.8%-11.8%
5 y5 years-19.7%-19.7%

TAK Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.8%at low-11.8%at low
5 y5-year-19.7%at low-20.1%at low
alltimeall time-23.4%+587.0%-24.2%+241.6%

TAK Total assets History

DateAnnualQuarterly
Mar 2025
$95.22B(-4.6%)
$95.22B(-1.0%)
Dec 2024
-
$96.20B(-5.7%)
Sep 2024
-
$102.04B(+1.2%)
Jun 2024
-
$100.84B(+1.0%)
Mar 2024
$99.82B(-4.7%)
$99.82B(-1.0%)
Dec 2023
-
$100.85B(+1.3%)
Sep 2023
-
$99.55B(-2.6%)
Jun 2023
-
$102.16B(-2.5%)
Mar 2023
$104.75B(-3.0%)
$104.75B(+1.7%)
Dec 2022
-
$103.00B(+2.0%)
Sep 2022
-
$100.98B(-1.9%)
Jun 2022
-
$102.97B(-4.6%)
Mar 2022
$107.97B(-7.8%)
$107.97B(-2.2%)
Dec 2021
-
$110.35B(-1.6%)
Sep 2021
-
$112.20B(-2.0%)
Jun 2021
-
$114.50B(-2.2%)
Mar 2021
$117.05B(-1.3%)
$117.05B(-1.7%)
Dec 2020
-
$119.13B(+1.4%)
Sep 2020
-
$117.48B(+0.2%)
Jun 2020
-
$117.23B(-1.2%)
Mar 2020
$118.63B(-4.6%)
$118.63B(-0.9%)
Dec 2019
-
$119.67B(+0.3%)
Sep 2019
-
$119.31B(-5.0%)
Jun 2019
-
$125.59B(+1.0%)
Mar 2019
$124.40B(+221.9%)
$124.40B(+138.0%)
Dec 2018
-
$52.26B(+39.0%)
Sep 2018
-
$37.60B(-0.1%)
Jun 2018
-
$37.64B(-2.6%)
Mar 2018
$38.64B(-0.6%)
$38.64B(-1.2%)
Dec 2017
-
$39.12B(+0.6%)
Sep 2017
-
$38.90B(+0.3%)
Jun 2017
-
$38.79B(-0.2%)
Mar 2017
$38.88B(+14.3%)
$38.88B(+9.2%)
Dec 2016
-
$35.61B(-5.2%)
Sep 2016
-
$37.56B(+1.2%)
Jun 2016
-
$37.13B(+9.1%)
DateAnnualQuarterly
Mar 2016
$34.02B(-4.9%)
$34.02B(-2.2%)
Dec 2015
-
$34.78B(-1.1%)
Sep 2015
-
$35.15B(-0.2%)
Jun 2015
-
$35.21B(-1.6%)
Mar 2015
$35.79B(-19.4%)
$35.79B(-8.1%)
Dec 2014
-
$38.95B(-6.8%)
Sep 2014
-
$41.79B(-4.5%)
Jun 2014
-
$43.75B(-1.5%)
Mar 2014
$44.40B(+3.2%)
$44.40B(+5.3%)
Dec 2013
-
$42.18B(-3.0%)
Sep 2013
-
$43.47B(+8.8%)
Jun 2013
-
$39.94B(-7.2%)
Mar 2013
$43.04B(-1.8%)
$43.04B(-2.2%)
Dec 2012
-
$44.00B(-1.9%)
Sep 2012
-
$44.85B(+2.6%)
Jun 2012
-
$43.70B(-0.3%)
Mar 2012
$43.82B(+30.8%)
$43.82B(-0.5%)
Dec 2011
-
$44.03B(-3.4%)
Sep 2011
-
$45.60B(+35.6%)
Jun 2011
-
$33.62B(+0.4%)
Mar 2011
$33.49B(+11.0%)
$33.49B(+1.8%)
Dec 2010
-
$32.88B(+1.8%)
Sep 2010
-
$32.31B(+6.5%)
Jun 2010
-
$30.33B(+0.5%)
Mar 2010
$30.18B(+8.3%)
$30.18B(+2.0%)
Dec 2009
-
$29.60B(-2.9%)
Sep 2009
-
$30.47B(+9.3%)
Mar 2009
$27.88B(-2.3%)
$27.88B(-1.0%)
Dec 2008
-
$28.15B
Mar 2008
$28.52B(+9.5%)
-
Mar 2007
$26.05B(+0.9%)
-
Mar 2006
$25.83B(+8.8%)
-
Mar 2005
$23.75B(+6.0%)
-
Mar 2004
$22.41B(+28.4%)
-
Mar 2003
$17.45B(+18.0%)
-
Mar 2002
$14.79B(+6.7%)
-
Mar 2001
$13.86B
-

FAQ

  • What is Takeda Pharmaceutical Company Limited annual total assets?
  • What is the all time high annual total assets for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited annual total assets year-on-year change?
  • What is Takeda Pharmaceutical Company Limited quarterly total assets?
  • What is the all time high quarterly total assets for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited quarterly total assets year-on-year change?

What is Takeda Pharmaceutical Company Limited annual total assets?

The current annual total assets of TAK is $95.22B

What is the all time high annual total assets for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high annual total assets is $124.40B

What is Takeda Pharmaceutical Company Limited annual total assets year-on-year change?

Over the past year, TAK annual total assets has changed by -$4.60B (-4.61%)

What is Takeda Pharmaceutical Company Limited quarterly total assets?

The current quarterly total assets of TAK is $95.22B

What is the all time high quarterly total assets for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high quarterly total assets is $125.59B

What is Takeda Pharmaceutical Company Limited quarterly total assets year-on-year change?

Over the past year, TAK quarterly total assets has changed by -$4.60B (-4.61%)
On this page